Biogen Inc. buy HC Wainwright
Start price
26.07.23
/
50%
€243.00
Target price
26.07.24
€293.57
Performance (%)
-19.94%
End price
27.07.24
€194.55
Summary
This prediction ended on 27.07.24 with a price of €194.55. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.94%. HC_Wainwright has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | 2.372% | 2.372% | 54.860% | -23.684% |
| iShares Core DAX® | -1.283% | 4.209% | 7.084% | 64.252% |
| iShares Nasdaq 100 | -3.338% | -1.744% | 26.177% | 84.969% |
| iShares Nikkei 225® | -4.286% | -1.621% | 44.320% | 79.253% |
| iShares S&P 500 | -2.311% | -0.096% | 20.823% | 68.079% |
Comments by HC_Wainwright for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $325.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von HC_Wainwright gewählte maximale Laufzeit wurde überschritten